Staging Laparoscopy After Neoadjuvant Treatment for Pancreatic Cancer to Prevent Non-Therapeutic Laparotomy
A SL just prior to surgical exploration in patients with PDAC following neoadjuvant treatment was able to detect occult metastases with a NNT of 8. Tailored use of SL only in patients with one or two risk factors would further lower this NNT.
Authors
- C. Yung Nio
- Esther N. Dekker (ORCID: https://orcid.org/0000-0002-3040-6736)
- Marcel G.W. Dijkgraaf
- Mike S L Liem
- Marjolein Y.V. Homs
- Jacob L. van Dam
- Quisette P. Janssen
- Gijs A Patijn
- Bas Groot Koerkamp
- Ignace H. de Hingh
- Olivier R. Busch
- Ronald M. van Dam
- B. Marion van der Kolk
- Hjalmar C. van Santvoort
- Johanna W. Wilmink
- Marc G. Besselink
- Casper H.J. van Eijck
- for the Dutch Pancreatic Cancer Group
- Sebastiaan Festen
- Geertjan van Tienhoven
- Ingmar F. Rompen
- Thomas F. Stoop
- Erwin van der Harst
Institutions
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Catharina Ziekenhuis (NL)
- Medisch Spectrum Twente (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- OLVG (NL)
- Amphia Ziekenhuis (NL)
- Amsterdam Neuroscience (NL)
- Maasstad Ziekenhuis (NL)
- Isala (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- University of Colorado Anschutz Medical Campus (US)
- Amsterdam University of Applied Sciences (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1097/sla.0000000000007025
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00